Biotech Breakthrough: Zivo Bioscience Unveils Revolutionary Non-Antibiotic Treatment for Poultry Disease

Zivo Bioscience, Inc., a pioneering biotech/agtech R&D company, has just announced a game-changing development in the battle against coccidiosis in broiler chickens. In a recent 42-day coccidiosis challenge study, the company's innovative immune-modulating treatment has shown remarkable efficacy, setting a new standard in poultry health management. This breakthrough product, designed for inclusion in poultry feed, enhances the birds' immune response, enabling them to effectively combat the debilitating effects of coccidiosis without relying on antibiotics.